Man

Marcelo Adan Garrido Salvo

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Líneas de Investigación


Gastric cancer treatments, tumor heterogeneity and targeted therapies, precision oncology

Educación

  •  Medico cirujano, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1997
  •  medicina interna, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2001
  •  medico oncologo, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2007

Experiencia Académica

  •   Instructor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Santiago, Chile

    2003 - 2007

  •   Profesor Asistente Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Santiago, Chile

    2007 - A la fecha

Experiencia Profesional

  •   Medico intensivista Full Time

    HOSPITAL DE LOS ANDES

    Los Andes, Chile

    2002 - 2003

Premios y Distinciones

  •   Beca Presidente de la Republica

    Gobierno de Chile

    Chile, 1992

    Beca de estudios entregada por S.E. Presidente Patricio Aylwin Azocar

  •   Premio al mejor graduado

    UNIVERSIDAD AUSTRAL DE CHILE

    Chile, 1995

    Premio al mejor graduado de Medicina

  •   Beca Medicina Interna

    MINISTERIO DE SALUD

    Chile, 1998

    Beca de Medicina interna UC

  •   Beca de Oncologia

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Chile, 2004

    Beca del Departamento de Hematologia y Oncologia PUC


 

Article (13)

High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study
Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
Chilean Gastric Cancer Task Force A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Angiogenesis inhibitors in early development for gastric cancer
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial
The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma
Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer
Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Proyecto (1)

Mechanisms of resistance to immunotherapy based on checkpoint inhibitors in metastatic gastric cancers
12
Marcelo Garrido

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Miguel Cordova

Estudiando de Doctorado

Departamento de Posgrado

Universidad de Chile

Santiago, Chile

2
FERNANDO CROVARI

Jefe Departamento

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Cesar Sanchez

Profesor asistente

Hematologia-oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

santiago, Chile

2
Ignacio Retamal

Docente

Universidad de Los Andes

Santiago, Chile

2
Ricardo Armisen

Associate Professor

Centro de Genética y Genómica

Universidad del Desarrollo

Santiago, Chile

2
María Maturana

Bioquimico

Pontificia Universidad Católica de Chile

Santiago, Chile

2
ALEJANDRO CORVALAN

Associate Professor

Hematology and Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

2
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Francisco Acevedo

Medico Oncologo

Hemato Oncologia

Pontificia Universidad Católica de Chile

Santiago, Chile

1
María Rodríguez

Profesora Asociada

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Erica Koch

Oncólogo Médico

Red de Salud UC Christus

Santiago, Chile

1
Manuel Espinoza

Profesor Asociado

Salud Pública

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

1
Bruno Nervi

Associated Professor

Hematology - Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile